Group One Trading
HRMY icon

Group One Trading’s Harmony Biosciences HRMY Stock Holding History

Group One Trading’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
123,100
+106,100
+624% +$3.48M 0.01% 1590
2025
Q4 		$636K Sell
17,000
-7,800
-31% -$256K ﹤0.01% 3277
2025
Q3 		$683K Buy
24,800
+9,800
+65% +$338K ﹤0.01% 3390
2025
Q2 		$474K Sell
15,000
-200
-1% -$6.43K ﹤0.01% 3478
2025
Q1 		$504K Buy
+15,200
New +$545K ﹤0.01% 3076
2024
Q2 		– Sell
-4,100
Closed -$138K – 7050
2024
Q1 		$138K Sell
4,100
-4,000
-49% -$128K ﹤0.01% 3865
2023
Q4 		$262K Buy
8,100
+8,000
+8,000% +$223K ﹤0.01% 3620
2023
Q3 		$3.28K Sell
100
-30,500
-100% -$1.06M ﹤0.01% 6880
2023
Q2 		$1.08M Buy
30,600
+30,500
+30,500% +$1.05M ﹤0.01% 2295
2023
Q1 		$3.27K Buy
+100
New +$4.55K ﹤0.01% 6466

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Group One Trading's HRMY Position: Q4 2024 in Review

Group One Trading sold out of Harmony Biosciences (HRMY) in Q4 2024, closing a stake of 242 shares — an estimated $9.68K sold.

Group One Trading first reported a position in HRMY in Q1 2023 and held it in 2 quarters. The position peaked at $134K in Q1 2023. 247 funds tracked by Wall St. Rank hold HRMY as of Q4 2024.

  • Group One Trading reported no remaining Harmony Biosciences position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 242 Harmony Biosciences shares in Q4 2024, an estimated $9.68K.
  • Group One Trading first reported a position in Harmony Biosciences in Q1 2023 and held it in 2 quarters.
  • Group One Trading's Harmony Biosciences position peaked at $134K in Q1 2023.
  • 247 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.